These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21756244)

  • 41. Risk factors for fatal scorpion envenoming among Brazilian children: a case-control study.
    Almeida ACC; Carvalho FM; Mise YF
    Trans R Soc Trop Med Hyg; 2021 Sep; 115(9):975-983. PubMed ID: 34352889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of antivenom therapy for neutralizing circulating venom antigens in patients stung by Tityus serrulatus scorpions.
    De Rezende NA; Dias MB; Campolina D; Chavez-Olortegui C; Diniz CR; Amaral CF
    Am J Trop Med Hyg; 1995 Mar; 52(3):277-80. PubMed ID: 7694971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Report of a WHO workshop on the standardization and control of antivenoms.
    Theakston RD; Warrell DA; Griffiths E
    Toxicon; 2003 Apr; 41(5):541-57. PubMed ID: 12676433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scorpion sting in children in the Jerusalem area: a review of 54 cases.
    Dudin AA; Rambaud-Cousson A; Thalji A; Juabeh II; Abu-Libdeh B
    Ann Trop Paediatr; 1991; 11(3):217-23. PubMed ID: 1719920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Scorpion envenomation and antivenom therapy.
    Sofer S; Shahak E; Gueron M
    J Pediatr; 1994 Jun; 124(6):973-8. PubMed ID: 8201489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel human recombinant antibody fragment capable of neutralizing Mexican scorpion toxins.
    Riaño-Umbarila L; Olamendi-Portugal T; Morelos-Juárez C; Gurrola GB; Possani LD; Becerril B
    Toxicon; 2013 Dec; 76():370-6. PubMed ID: 24067940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
    Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B
    J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of Scorpion Antivenom in Grade III and IV Scorpion Envenomation.
    Prasad R; Kumar A; Mishra OP; Singh TB; Singh A
    Indian J Pediatr; 2018 Jul; 85(7):576. PubMed ID: 29704171
    [No Abstract]   [Full Text] [Related]  

  • 49. Serotherapy in scorpion envenomation: a randomised controlled trial.
    Abroug F; ElAtrous S; Nouira S; Haguiga H; Touzi N; Bouchoucha S
    Lancet; 1999 Sep; 354(9182):906-9. PubMed ID: 10489950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antivenoms for snakebite envenomings.
    Gutiérrez JM; León G; Lomonte B; Angulo Y
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and Epidemiological Aspects of Scorpionism in the World: A Systematic Review.
    Santos MS; Silva CG; Neto BS; Grangeiro Júnior CR; Lopes VH; Teixeira Júnior AG; Bezerra DA; Luna JV; Cordeiro JB; Júnior JG; Lima MA
    Wilderness Environ Med; 2016 Dec; 27(4):504-518. PubMed ID: 27912864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatments for Centruroides exilicauda envenomation.
    Rachesky IJ; Banner W; Dansky J; Tong T
    Am J Dis Child; 1984 Dec; 138(12):1136-9. PubMed ID: 6507396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The neutralizing capacity of Androctonus crassicauda antivenom against Mesobuthus eupeus scorpion venom.
    Ozkan O; Carhan A
    Toxicon; 2008 Aug; 52(2):375-9. PubMed ID: 18625264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Broadening the neutralizing capacity of a family of antibody fragments against different toxins from Mexican scorpions.
    Rodríguez-Rodríguez ER; Olamendi-Portugal T; Serrano-Posada H; Arredondo-López JN; Gómez-Ramírez I; Fernández-Taboada G; Possani LD; Anguiano-Vega GA; Riaño-Umbarila L; Becerril B
    Toxicon; 2016 Sep; 119():52-63. PubMed ID: 27212628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antivenom for critically ill children with neurotoxicity from scorpion stings.
    Boyer LV; Theodorou AA; Berg RA; Mallie J; ; Chávez-Méndez A; García-Ubbelohde W; Hardiman S; Alagón A
    N Engl J Med; 2009 May; 360(20):2090-8. PubMed ID: 19439743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination of two antibody fragments F(ab')(2)/Fab: an alternative for scorpion envenoming treatment.
    Sami-Merah S; Hammoudi-Triki D; Martin-Eauclaire MF; Laraba-Djebari F
    Int Immunopharmacol; 2008 Oct; 8(10):1386-94. PubMed ID: 18687300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What is the treatment for the cardiovascular manifestations of scorpion envenomation?
    Gueron M; Ovsyshcher I
    Toxicon; 1987; 25(2):121-30. PubMed ID: 3576632
    [No Abstract]   [Full Text] [Related]  

  • 58. Scorpion envenoming,a step ahead.
    Bawaskar HS; Bawaskar PH
    Indian Pediatr; 2015 Apr; 52(4):289-90. PubMed ID: 25929623
    [No Abstract]   [Full Text] [Related]  

  • 59. Meta-analysis of controlled studies on immunotherapy in severe scorpion envenomation: a commentary.
    Foëx BA
    Emerg Med J; 2011 Nov; 28(11):915-6. PubMed ID: 21670073
    [No Abstract]   [Full Text] [Related]  

  • 60. Envenomation by the scorpion Centruroides sculpturatus.
    Curry SC; Vance MV; Ryan PJ; Kunkel DB; Northey WT
    J Toxicol Clin Toxicol; 1983-1984; 21(4-5):417-49. PubMed ID: 6381751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.